"10.1371_journal.pone.0085248","plos one","2014-01-07T00:00:00Z","Carmen Martínez; Ana M Ortiz; Yasmina Juarranz; Amalia Lamana; Iria V Seoane; Javier Leceta; Rosario García-Vicuña; Rosa P Gomariz; Isidoro González-Álvaro","Departamento de Biología Celular, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain; Servicio de Reumatología, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria la Princesa, Madrid, Spain; Departamento de Biología Celular, Facultad de Biología, Universidad Complutense de Madrid, Madrid, Spain","Conceived and designed the experiments: CM AMO RPG IG-A. Performed the experiments: CM YJ AL IVS IG-A AMO JL. Analyzed the data: IG-A CM RPG AMO. Wrote the paper: CM IG-A RPG RG-V.","A patent application (P201230827) for the use of VIP as a marker of prognostic in autoimmune diseases has been deposited by the Fundación de Investigación Biomédica del Hospital Universitario de la Princesa at the Oficina Española de Patentes y Marcas. The full name of the patent application is: VIP use as a prognostic marker of autoimmune diseases. This does not alter the authors adherence to all the PLOS ONE policies.","2014","01","Carmen Martínez","CM",9,TRUE,4,7,4,4,TRUE,TRUE,TRUE,1,"9",TRUE
